Second-line option for metastatic RCC

被引：0
|
作者：
Vanessa Marchesi
机构：
来源：
Nature Reviews Clinical Oncology | 2013年 / 10卷 / 6期
关键词：
D O I：
10.1038/nrclinonc.2013.74
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 305
相关论文
共 50 条
  • [1] Thalidomide, interferon-alpha, and capecitabine as second-line therapy for metastatic renal cell cancer(RCC).
    Minor, DR
    Amato, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 430S - 430S
  • [2] Cabopoint: a phase II study of second-line cabozantinib in patients with metastatic renal cell carcinoma (RCC)
    Ivanyi, P.
    Albiges, L.
    Schmidinger, M.
    Taguieva-Pioger, N.
    Perol, D.
    Gruenwald, V
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 274 - 274
  • [3] CaboPoint: A phase II study of second-line cabozantinib in patients with metastatic renal cell carcinoma (RCC)
    Albiges, L.
    Schmidinger, M.
    Taguieva-Pioger, N.
    Perol, D.
    Gruenwald, V.
    ANNALS OF ONCOLOGY, 2020, 31 : S608 - S609
  • [4] From neoadjuvant to second-line therapeutic options for RCC patients
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 : S190 - S194
  • [5] Integrative genomic profiling of RCC treated with second-line nivolumab
    Vats, Pankaj
    Dhanasekaran, Saravana
    Malik, Rohit
    Zhang, Yupin
    Cao, Xuhong
    Su, Fengyun
    Wang, Rui
    Ali, Alicia
    Erickson, Stephanie
    Dahl, Megan
    Voliva, Charles
    Mehra, Rohit
    Chinnaiyan, Arul
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Second-Line Option for Patients with metastatic Colorectal Cancer Ramucirumab effective in rapid First-line Progression
    Rudesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (04) : 213 - 213
  • [7] Another option for metastatic RCC
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2013, 10 (11) : 607 - 607
  • [8] Cabozantinib as a second-line treatment option in hepatocellular carcinoma
    D'Angelo, Alberto
    Sobhani, Navid
    Bagby, Stefan
    Casadei-Gardini, Andrea
    Roviello, Giandomenico
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (06) : 623 - 629
  • [9] Atomoxetine is a second-line medication treatment option for ADHD
    Ghuman, Jaswinder K.
    Hutchison, Shari L.
    EVIDENCE-BASED MENTAL HEALTH, 2014, 17 (04) : 108 - 108
  • [10] Second-line therapy for metastatic colorectal cancer
    Price, Timothy J.
    LANCET ONCOLOGY, 2015, 16 (05): : 476 - 477
12345